{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:32:33Z","timestamp":1757626353193,"version":"3.44.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Gilead","award":["CO-UK-412-5430"],"award-info":[{"award-number":["CO-UK-412-5430"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24202-0","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T07:22:04Z","timestamp":1756106524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cI have the vaccine in my body\u201d: perceptions of female sex workers after enrolling in a phase IIb HIV vaccine and pre-exposure prophylaxis trial in urban Tanzania"],"prefix":"10.1186","volume":"25","author":[{"given":"Edith A.M","family":"Tarimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masunga K.","family":"Iseselo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel S.","family":"Ambikile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gift","family":"Lukumay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Munseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Bakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eligius","family":"Lyamuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Kawuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PrEPVacc Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"24202_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Fact sheet 2024 - Latest global and regional HIV statistics on the status of the AIDS epidemic. 2024; Available from: https:\/\/www.unaids.org\/en"},{"key":"24202_CR2","doi-asserted-by":"publisher","unstructured":"Jin H, Restar A, Beyrer C. Overview of the epidemiological conditions of HIV among key populations in Africa. J Int AIDS Soc. 2021;24(S3). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/jia2.25716","DOI":"10.1002\/jia2.25716"},{"key":"24202_CR3","doi-asserted-by":"publisher","unstructured":"Ngurukiri P, Babu H, Kung M, Nyamweya C, Id AM, Study MF et al. PLOS GLOBAL PUBLIC HEALTH The epidemiology of HIV infection among female sex workers in Nairobi, Kenya : A structural determinants and life-course perspective. 2024;1\u201319. Available from: https:\/\/doi.org\/10.1371\/journal.pgph.0001529","DOI":"10.1371\/journal.pgph.0001529"},{"issue":"1","key":"24202_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2625-0","volume":"17","author":"M Mutagoma","year":"2017","unstructured":"Mutagoma M, Nyirazinyoye L, Sebuhoro D, Riedel DJ, Ntaganira J. Syphilis and HIV prevalence and associated factors to their co-infection, hepatitis B and hepatitis C viruses prevalence among female sex workers in Rwanda. BMC Infect Dis. 2017;17(1): 525. https:\/\/doi.org\/10.1186\/s12879-017-2625-0.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"24202_CR5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1177\/0956462420917848","volume":"31","author":"M Mizinduko","year":"2020","unstructured":"Mizinduko M, Moen K, Likindikoki S, Mwijage A, Leyna G, Makyao N, et al. HIV prevalence and associated risk factors among female sex workers in Dar es Salaam, Tanzania: tracking the epidemic. Int J STD AIDS. 2020;31(10):950\u20137. https:\/\/doi.org\/10.1177\/0956462420917848.","journal-title":"Int J STD AIDS"},{"key":"24202_CR6","doi-asserted-by":"publisher","unstructured":"Munseri PJ, Kroidl A, Nilsson C, Joachim A, Geldmacher C, Mann P et al. Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial. Goepfert PA, editor. PLoS One. 2015;10(4):e0119629. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0119629","DOI":"10.1371\/journal.pone.0119629"},{"issue":"8","key":"24202_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1089\/aid.2016.0251","volume":"33","author":"A Joachim","year":"2017","unstructured":"Joachim A, Munseri PJ, Nilsson C, Bakari M, Aboud S, Lyamuya EF, et al. Three-year durability of immune responses induced by HIV-DNA and HIV-modified vaccinia virus Ankara and effect of a late HIV-modified vaccinia virus Ankara boost in Tanzanian volunteers. AIDS Res Hum Retroviruses. 2017;33(8):880\u20138. https:\/\/doi.org\/10.1089\/aid.2016.0251.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"24202_CR8","doi-asserted-by":"publisher","unstructured":"Viegas EO, Kroidl A, Munseri PJ, Missanga M, Nilsson C, Tembe N et al. Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140\/GLA vaccines in a phase II randomized factorial trial design. Landay A, editor. PLoS One. 2018;13(11):e0206838. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0206838","DOI":"10.1371\/journal.pone.0206838"},{"key":"24202_CR9","doi-asserted-by":"crossref","unstructured":"Bakari M, Aboud S, Nilsson C, Francis J, Buma D, Moshiro C et al. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine. 2011;29(46):8417\u201328. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11012102","DOI":"10.1016\/j.vaccine.2011.08.001"},{"issue":"1","key":"24202_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-722","volume":"13","author":"PJ Munseri","year":"2013","unstructured":"Munseri PJ, Bakari M, Janabi M, Aris E, Aboud S, Hejdeman B, et al. Declining HIV-1 prevalence and incidence among police officers - a potential cohort for HIV vaccine trials, in Dar Es salaam, Tanzania. BMC Public Health. 2013;13(1):1\u20138.","journal-title":"BMC Public Health"},{"key":"24202_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-10-292","volume":"10","author":"EA Tarimo","year":"2010","unstructured":"Tarimo EA, Thorson A, Kohi TW, Mwami J, Bakari M, Sandstr\u00f6m E, et al. Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar Es salaam, Tanzania. BMC Public Health. 2010;10:1\u201311.","journal-title":"BMC Public Health"},{"key":"24202_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-283","author":"EAM Tarimo","year":"2011","unstructured":"Tarimo EAM, Thorson A, Kohi TW, Bakari M, Sandstrom E, Mhalu F, et al. A qualitative evaluation of volunteers\u2019 experiences in a phase I\/II HIV vaccine trial in Tanzania. BMC Infect Dis. 2011. https:\/\/doi.org\/10.1186\/1471-2334-11-283.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"24202_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276404","volume":"17","author":"EAM Tarimo","year":"2022","unstructured":"Tarimo EAM, Ambikile J, Munseri P, Bakari M. Personal experiences following acquiring HIV infection while volunteering in phase I\/II HIV vaccine trials: a qualitative study from Tanzania. PLoS One. 2022;17(10): e0276404. https:\/\/doi.org\/10.1371\/journal.pone.0276404.","journal-title":"PLoS One"},{"issue":"5","key":"24202_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/QAI.0000000000003097","volume":"91","author":"D Faini","year":"2022","unstructured":"Faini D, Msafiri F, Munseri P, Bakari M, Lyamuya E, Sandstr\u00f6m E, et al. The prevalence, incidence, and risk factors for HIV among female sex workers\u2014a cohort being prepared for a phase IIb HIV vaccine trial in Dar es Salaam, Tanzania. JAIDS J Acquir Immune Defic Syndr. 2022;91(5):439\u201348. https:\/\/doi.org\/10.1097\/QAI.0000000000003097.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"9883","key":"24202_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"issue":"22","key":"24202_CR16","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US preventive services task force. JAMA. 2019;321(22):2214\u201330.","journal-title":"JAMA"},{"issue":"1","key":"24202_CR17","first-page":"100","volume":"176","author":"K Underhill","year":"2017","unstructured":"Underhill K, Morrow KM, Colleran C, Calabrese SK, Operario D, Salovey P, et al. Explaining the efficacy of Pre-Exposure prophylaxis (PrEP) for HIV prevention: A qualitative study of message framing and messaging preferences among US men who have sex with men. AIDS Bhehaviour. 2017;176(1):100\u20136.","journal-title":"AIDS Bhehaviour"},{"key":"24202_CR18","unstructured":"World Health Organization. Guideline on When To Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. 2015;(September):1\u201376."},{"issue":"5","key":"24202_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Van Damme","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1202614.","journal-title":"N Engl J Med"},{"key":"24202_CR20","doi-asserted-by":"publisher","unstructured":"O Murchu E, Marshall L, Teljeur C, Harrington P, Hayes C, Moran P et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478. Available from: https:\/\/bmjopen.bmj.com\/lookup\/doi\/https:\/\/doi.org\/10.1136\/bmjopen-2020-048478","DOI":"10.1136\/bmjopen-2020-048478"},{"key":"24202_CR21","unstructured":"National AIDS, Control Programme T (NACP). National Guidelines for the Management of Hiv and Aids. Development. 2019;7(5,371,780,231.09):2,274,923,575.00-29.08. Available from: https:\/\/nacp.go.tz\/download\/national-guidelines-for-the-management-of-hiv-and-aids-april-2019\/"},{"key":"24202_CR22","unstructured":"The United Republic of Tanzania, National Bureau of Statistics and President\u2019s Office. The 2022 Population and Housing Census: Administrative UnitsPopulation DistributionReport [Internet]. 2022. Available from: https:\/\/www.nbs.go.tz\/nbs\/takwimu\/Census2022\/Administrative_units_Population_Distribution_Report_Tanzania_volume1a.pdf"},{"issue":"6","key":"24202_CR23","first-page":"2061","volume":"26","author":"LJ Goldsmith","year":"2021","unstructured":"Goldsmith LJ. Using framework analysis in applied qualitative research. Qual Rep. 2021;26(6):2061\u201376.","journal-title":"Qual Rep"},{"key":"24202_CR24","doi-asserted-by":"crossref","unstructured":"Graneheim U, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105\u201312. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0260691703001515","DOI":"10.1016\/j.nedt.2003.10.001"},{"key":"24202_CR25","doi-asserted-by":"crossref","unstructured":"Shannon K, Goldenberg SM, Deering KN, Strathdee SA. HIV infection among female sex workers in concentrated and high prevalence epidemics. Curr Opin HIV AIDS. 2014;9(2):174\u201382. Available from: http:\/\/journals.lww.com\/01222929-201403000-00011","DOI":"10.1097\/COH.0000000000000042"},{"key":"24202_CR26","unstructured":"Tanzania Commission for AIDS (TACAIDS). Tanzania HIV Impact Survey (A population-Based HIV Impact Assessment) THIS 2026\u2009\u2013\u20092017 [Internet]. 2018. Available from: https:\/\/phia.icap.columbia.edu\/wp-content\/uploads\/2020\/02\/FINAL_THIS-2016-2017_Final-Report__06.21.19_for-web_TS.pdf"},{"issue":"2","key":"24202_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1465-3362.2009.00091.x","volume":"29","author":"CL Johnston","year":"2010","unstructured":"Johnston CL, Callon C, Li K, Wood E, Kerr T. Offer of financial incentives for unprotected sex in the context of sex work. Drug Alcohol Rev. 2010;29(2):144\u20139.","journal-title":"Drug Alcohol Rev"},{"issue":"9","key":"24202_CR28","first-page":"1168","volume":"31","author":"G George","year":"2019","unstructured":"George G, Nene S, Beckett S, Durevall D, Lindskog A, Govender K. Greater risk for more money: the economics of negotiating condom use amongst sex workers in South Africa. AIDS Care - Psychol Socio-Medical Asp AIDS\/HIV. 2019;31(9):1168\u201371.","journal-title":"AIDS Care - Psychol Socio-Medical Asp AIDS\/HIV"},{"key":"24202_CR29","doi-asserted-by":"publisher","unstructured":"Farghaly AG, Alkassabany YM, El-Ghitany EM, HBV. HCV and HIV among female sex workers; is it a health problem? Sex Relatsh Ther. 2020;35(4):462\u201377. Available from: https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/14681994.2020.1778165","DOI":"10.1080\/14681994.2020.1778165"},{"key":"24202_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25650","author":"J Stone","year":"2021","unstructured":"Stone J, Mukandavire C, Boily M, Fraser H, Mishra S, Schwartz S, et al. Estimating the contribution of key populations towards HIV transmission in South Africa. J Int AIDS Soc. 2021. https:\/\/doi.org\/10.1002\/jia2.25650.","journal-title":"J Int AIDS Soc"},{"key":"24202_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7673014","volume":"2016","author":"S Nakanwagi","year":"2016","unstructured":"Nakanwagi S, Matovu JKB, Kintu BN, Kaharuza F, Wanyenze RK. Facilitators and barriers to linkage to HIV care among female sex workers receiving HIV testing services at a Community-Based organization in Periurban uganda: A qualitative study. J Sex Transm Dis. 2016;2016:1\u20138.","journal-title":"J Sex Transm Dis"},{"key":"24202_CR32","doi-asserted-by":"publisher","unstructured":"Faini D, Munseri P, Bakari M, Sandstr\u00f6m E, Faxelid E, Hanson C. I did not plan to have a baby. This is the outcome of our work: a qualitative study exploring unintended pregnancy among female sex workers. BMC Womens Health. 2020;20(1):267. Available from: https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12905-020-01137-9","DOI":"10.1186\/s12905-020-01137-9"},{"key":"24202_CR33","doi-asserted-by":"publisher","unstructured":"Makhakhe NF, Sliep Y, Meyer-Weitz A. Whatever is in the ARVs, is Also in the PrEP Challenges Associated With Oral Pre-exposure Prophylaxis Use Among Female Sex Workers in South Africa. Front Public Heal. 2022;10. Available from: https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fpubh.2022.691729\/full","DOI":"10.3389\/fpubh.2022.691729\/full"},{"key":"24202_CR34","doi-asserted-by":"crossref","unstructured":"Martin VO, Tesha NA, Sunguya BF. Uptake of Oral HIV Pre-Exposure Prophylaxis (PrEP) and Associated Factors among Female Sex Workers in Tanga, Tanzania. Viruses. 2023;15(10):2125. Available from: https:\/\/www.mdpi.com\/1999-4915\/15\/10\/2125","DOI":"10.3390\/v15102125"},{"issue":"8","key":"24202_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2021-058611","volume":"12","author":"SW Beckham","year":"2022","unstructured":"Beckham SW, Mantsios A, Galai N, Likindikoki S, Mbwambo J, Davis W, et al. Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in tanzania: A mixed-methods study. BMJ Open. 2022;12(8):1\u201310.","journal-title":"BMJ Open"},{"issue":"7541","key":"24202_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/bmj.332.7541.605","volume":"332","author":"MM Cassell","year":"2006","unstructured":"Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles\u2019 heel of innovations in HIV prevention? BMJ. 2006;332(7541):605\u20137. https:\/\/doi.org\/10.1136\/bmj.332.7541.605.","journal-title":"BMJ"},{"key":"24202_CR37","doi-asserted-by":"crossref","unstructured":"Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M et al. HIV Sexual Risk Behavior Over 36 Months of Follow-Up in the World\u2019s First HIV Vaccine Efficacy Trial. JAIDS J Acquir Immune Defic Syndr. 2005;39(1):90\u2013101. Available from: https:\/\/journals.lww.com\/00126334-200505010-00013","DOI":"10.1097\/01.qai.0000143600.41363.78"},{"issue":"1","key":"24202_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-01142-y","volume":"20","author":"D Twizelimana","year":"2020","unstructured":"Twizelimana D, Muula AS. Actions taken by female sex workers (FSWs) after condom failure in semi urban Blantyre, Malawi. BMC Womens Health. 2020;20(1): 273. https:\/\/doi.org\/10.1186\/s12905-020-01142-y.","journal-title":"BMC Womens Health"},{"issue":"3","key":"24202_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/sextrans-2011-050283","volume":"88","author":"J Bradley","year":"2012","unstructured":"Bradley J, Rajaram SP, Moses S, Boily MC, Ramesh BM, Isac S, et al. Why do condoms break? A study of female sex workers in Bangalore, south India. Sex Transm Infect. 2012;88(3):163\u201370. https:\/\/doi.org\/10.1136\/sextrans-2011-050283.","journal-title":"Sex Transm Infect"},{"key":"24202_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-023-01923-3","author":"A Hamidi","year":"2023","unstructured":"Hamidi A, Regmi P, van Teijlingen E. Facilitators and barriers to condom use in Middle East and North Africa: a systematic review. J Public Health. 2023. https:\/\/doi.org\/10.1007\/s10389-023-01923-3.","journal-title":"J Public Health"},{"issue":"3","key":"24202_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090938","volume":"9","author":"EAM Tarimo","year":"2014","unstructured":"Tarimo EAM, Munseri P, Aboud S, Bakari M, Mhalu F, Sandstrom E. Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I\/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania. PLoS One. 2014;9(3): e90938. https:\/\/doi.org\/10.1371\/journal.pone.0090938.","journal-title":"PLoS One"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24202-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24202-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24202-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:09:42Z","timestamp":1757455782000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24202-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24202"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24202-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"type":"electronic","value":"1471-2458"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"16 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PrEPVacc study received ethical approval from the National Ethics Committee in Tanzania (Approval number: NIMR\/HQ\/R.8a\/Vol.IX\/3333) and from the Muhimbili University of Health and Allied Sciences (Approval number: MUHAS-REC-11-2019-066), and it was conducted per the Declaration of Helsinki. Before commencement of data collection, the interviewer and the participants revisited the study information shared at previous visits to ensure the participants still recall what the qualitative study is about. They were assured of the confidentiality that even the clinic team would not get to know what they shared, unless with their permission. Clarification was made for anything they did not understand, and they were answered any question they had. When the interviewer was satisfied that the information has been understood and the participant(s) was in agreement, the participant was given two copies (one for the study and another one for the participant) of informed consent to sign and date. The participants in FGDs were taken through the same process in groups. In addition, the participants were requested that the interview would be audio-recorded, and the audios would be transcribed without disclosing their personal information. This anonymity was ensured by giving each participant a number from the start of IDI of FGD. Thus, written informed consent was obtained from all the potential study participants. The participants were assured of their freedom to participate or withdraw from the study at any time and that by doing so, they would not compromise the services they were entitled to during the study. Also all the participants were assured of their privacy. They were informed that the knowledge generated from the shared information will be disseminated in various forums anonymously without disclosing their personal identification. All the participants received transport compensation in 30,000 Tanzanian Shillings equivalent to $12 US Dollars. Also, the participants were reminded about available referral services if they needed health care or other support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2906"}}